General Biologicals

General Biologicals Gross Margin

The Gross Margin of General Biologicals (4117.TWO) as of Nov 5, 2026 is 27.63 %. In the previous year, Gross Margin was 2.99 % — a change of 823.88% (higher).

Gross Margin

27.63 %

YoY

823.88%

Last updated:

Gross Margin of General Biologicals is 2025 27.63 % . Gross Margin of General Biologicals was 2024 2.99 % . It decreases by 823.88% higher compared to the previous year.

For General Biologicals, the gross margin of 27.6% is down versus 51.1% a few years ago.

The General Biologicals Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
48.01 TWD
Jan 1, 2019
52.93 TWD
Jan 1, 2020
52.76 TWD
Jan 1, 2021
51.11 TWD
Jan 1, 2022
46.39 TWD
Jan 1, 2023
23.68 TWD
Jan 1, 2024
2.99 TWD
Jan 1, 2025
27.63 TWD
The General Biologicals Gross Margin history
YEARGross MarginYoY
27.63 %+823.88%
2.99 %-87.37%
23.68 %-48.96%
46.39 %-9.23%
51.11 %-3.13%
52.76 %-0.32%
52.93 %+10.25%
48.01 %+9.17%
43.97 %+48.20%
29.67 %-31.67%
43.42 %-5.59%
45.99 %+9,323.80%
0.49 %-21.65%
0.62 %+3.52%
0.60 %+7.23%
0.56 %+18.25%
0.47 %-7.47%
0.51 %-7.28%
0.55 %+14.26%
0.48 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

General Biologicals Stock analysis

What does General Biologicals do? General Biologicals Corp., headquartered in Baoshan, Hsinchu, Taiwan, operates in the Health Care sector, specifically within the Biotechnology industry. The company engages in research, development, manufacturing, and trading of diagnostics, pharmaceuticals, and medical supplies. Its main products include detection reagents, biological protein new drugs, P113, and medical supplies, distributed domestically and internationally. Listed on 4 July 2002, the company employs 63 people. General Biologicals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about General Biologicals stock

Gross Margin of General Biologicals is 27.63 % in 2025.

Gross Margin of General Biologicals changed from 2.99 % to 27.63 %, representing a 823.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin General Biologicals since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's General Biologicals with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — General Biologicals

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — General Biologicals